PHAN M. NGUYEN
Vista, CA **081
abig7q@r.postjobfree.com
QUALIFICATIONS
• Strong quantitative and qualitative research skills
• High level of computer aptitude
• Ability to multi-task in a fast-paced environment and interface well at all levels of the organization
• Strong attention to details
• Excellent oral and written communication skills
• Superior interpersonal skills
• Ability to independently organize and prioritize workflow to meet established timeframes
• Flexibility and willingness to learn and meet new challenges
• Big Picture thinker
• MBA student at California State University, San Marcos
PROFESSIONAL EXPERIENCE
GenVault Corp. – Carlsbad, CA
Software Support Specialist – contract (August 2009 – March 2010)
• Assisted in developing GenConnect Software used in biosample management; performed market
research/competition tracking and provided management with strategic development plans.
• Conducted WebEx training/demos of GenConnect Software, and provided customer support of pre and post
software sales; support marketing campaigns and web advertisement.
Kalypsys Inc. – San Diego, CA
Scientist I (2004 – 2008)
• Member of the Kalypsys New Target Assessment Team responsible for analyzing and monitoring market trends
of potential drug targets.
• Designed, developed, and optimized cell-based, biochemical, and radioligand binding assays using Kalypsys’s
µHTS (ultra High Throughput Screening) automated technologies.
• Supervised student interns with daily chemical and supply inventory, making buffer solutions, plasmid
preparations, and general lab maintenance duties.
• Characterized and validated novel, proprietary cancer target molecules.
• Established a flow cytometry lab at Kalypsys, and developed secondary follow up screen assays in a HTS (384-
well plate) format to support the ongoing Kalypsys’s aggressive pipeline.
Genoptix Inc. – San Diego, CA (2002 –2004)
Senior Research Associate
• Appointed by the company’s Chief Operating Officer to lead flow cytometry development projects for CLIA
certification.
• Examined the utility of optophoresis in the evaluation of clinical tumor samples for sensitivity to chemotherapeutic
agents.
• Provided first evidence that clinical breast carcinoma samples can be distinguished from normal adjacent tissue
using Optophoresis technology.
• Evaluated metastatic potential of various melanoma cell lines using optophoresis in a cytokine-dependent
experimental system.
Aviron – Mountain View, CA (2001 –2002)
Research Associate III
• Performed Hemagglutination Inhibition, Phenotype Plaque, and PCR assays of clinical trial patients who have
been vaccinated with intra-nasal flu vaccine and CMV.
• Wrote test reports, project summaries, protocols, and SOP for the Clinical Testing Laboratory Department .
Clontech Laboratories, Inc. – Palo Alto, CA (1997 –2001)
QC Associate II
• Conducted analysis of raw material, products in process and finished Clontech products. Performed alpha site
testing of new products specifically PCR enzymes, Antibodies, and Northern Blots.
• Collaborated with R&D scientists to review data and establish QC criteria for new PCR products; provide trouble-
shooting and formulate processes to improve established PCR products.
• Wrote PCR protocols for Quality Control Department
Production Associate
• Assisted with implementing new methods and technologies to enhance production operations
• Scaled up production of plasmid libraries
• Isolated human genomic DNA from human placenta to serve as a research tool
United States Army Reserve – Mountain View, CA (1992 –2000)
Medical Laboratory Specialist
• Trained in phlebotomy, urinalysis and hematology analysis, culture plating, hematocrit, and blood analyzer.
COMPUTER SKILLS
• Microsoft Office
• FileMaker Pro
• Graph Pad Prism
• Spotfire Analysis Tool
• SampleWare (Biomatrica)
• GenConnect (GenVault)
• WebEx
EDUCATION
UNIVERSITY OF CALIFORNIA, DAVIS
B.S. Physiology (June 1996)
CALIFORNIA STATE UNIVERSITY, SAN MARCOS
MBA (Candidate, December 2010)
PUBLICATIONS
Symons KT, Nguyen PM, Roppe J, Payne JE, Smith ND, Noble SA, Rosenkranz N, Zhang Y, Rao TS, Shiau AK, Hassig
CA. KLYP956, a non-imidazole based orally available inhibitor of iNOS dimerization. Mol Pharm, in press (2009).
Bonnefous C, Payne JE, Roppe J, Zhang H, Chen X, Symons KT, Nguyen PM, Sablad M, Rozenkrants N, Zhang Y,
Wang L, Severance D, Walsh JP, Yazdani N, Shiau AK, Noble SA, Rix P, Rao TS, Hassig CA and Smith ND. Discovery of
iNOS inhibitor Development Candidate KD7332 (Part 1): Identification of a Novel, Potent and Selective series of
Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models. J Med Chem, in press (2009).
Symons KT, Massari ME, Dozier S, Nguyen PM, Jenkins D, Herbert M, Gahman T, Noble SA, Rosenkranz N, Zhang Y,
Rao TS, Shiau AK, Hassig CA. Inhibition of inducible nitric oxide synthase expression by a novel small molecule activator
of the unfolded protein response. Curr Chem Genomics, 2:1-9. (2008).
Payne JE, Bonnefous C, Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Hoffman TZ, Rao TS, Shiau
AK, Malecha JW, Noble SA, Hager JH, Smith ND. Identification of KD5170: A novel mercaptoketone-based histone
deacetylase inhibitor. Bioorg Med Chem Lett, 18:6093-6096. (2008).
Wash PL, Hoffman TZ, Wiley BM, Bonnefous C, Smith ND, Sertic MS, Lawrence CM, Hassig CA, Symons KT, Guo X,
Nguyen PM, Annable T, Noble SA, Hager JH, Malecha JW. a-Mercaptoketone based histone deacetylase inhibitors.
Bioorg Med Chem Lett, 18:6482-6485. (2008).
Hassig CA, Symons KT, Guo X, Nguyen PM, Annable T, Wash PL, Payne JE, Bonnefous C, Hoffman TZ, Saven A, Wiley
BM, Sertic M, Malecha JW, Noble S, Smith ND, Muhammad J, Rao TS, Davis R, Hager JH. KD5170, a novel
mercaptoketone-based HDAC inhibitor that exhibits broad spectrum anti-tumor activity in vitro and in vivo. Mol Cancer
Ther, 7:1054-165. (2008).
Haichuan Zhang, Eugene Tu, Norbert D Hagen, Catherine A Schnabel, Michael J Paliotti, William Soo Hoo, Phan M
Nguyen, Josh R Kohrumel, William F Butler, Mirianas Chachisvillis, Philippe J Marchand. Time-of-flight optophoresis
analysis of live whole cells in microfluidic channels. Biomed Microdevices. 2004 Mar; 6:11-21.